首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Prognostic biological factors of radiation pneumonitis after stereotactic body radiation therapy combined with pulmonary perfusion imaging
【2h】

Prognostic biological factors of radiation pneumonitis after stereotactic body radiation therapy combined with pulmonary perfusion imaging

机译:立体定向放疗联合肺灌注成像对放射性肺炎预后的生物学影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Radiation pneumonitis (RP) is one of the most common dose-limiting toxicity syndromes in patients with thoracic malignant tumors receiving radiotherapy. The present study aimed to identify biological factors for the prediction of RP. Pulmonary perfusion imaging is capable of reflecting the differential functional activity of various regions of the lung, and in the present study, radiotherapy plans that were established on the basis that pulmonary perfusion images have high biological conformality, which may identify regions vulnerable to RP to spare them from radiation. A total of 46 patients with non-small cell lung cancer (NSCLC), exhibiting high and low levels of apurinic/apyrimidinic endonuclease-1 (Ape-1), intercellular adhesion molecule (ICAM)-1 and interleukin (IL)-17A prior to treatment, with SBRT with respective cut-off values of 4.2, 3.0 and 5.1 µg/l were stratified into groups A and B. Patients received radiation doses within the margin of the planning target volume. Stereotactic body radiation therapy (SBRT) was used for the treatment of NSCLC and single-photon emission computed tomography pulmonary perfusion imaging was used to assess all patients for the presence of RP. Furthermore, the serum levels of Ape-1, ICAM-1 and IL-17A were examined by ELISA. Prior to SBRT, perfusion images indicated that no RP was present in any of the patients, and 23 patients had high levels of Ape-1, ICAM-1 and IL-17A. After SBRT, 22 out of 23 patients in group A (95.65%) presented with RP and 1 patient (4.35%) had no RP. In group B, 6 out of 23 patients (26.09%) had RP and 17 patients (73.91%) had no RP after SBRT. The difference between the two groups in the incidence of RP was significant (P=1.66×10−12 <0.05). In conclusion, high levels of Ape-1, ICAM-1 and IL-17A are associated with an increased risk of RP. A further analysis should be performed in the future to verify whether these factors have significant prognostic value.
机译:放射性肺炎(RP)是接受放疗的胸部恶性肿瘤患者中最常见的剂量限制性毒性综合征之一。本研究旨在确定预测RP的生物学因素。肺灌注成像能够反映出肺各区域的差异功能活动,在本研究中,基于肺灌注图像具有高生物适形性而建立的放疗计划,可以确定易受RP影响的区域以免他们免受辐射。共有46例非小细胞肺癌(NSCLC)患者,其先前表现出高水平和低水平的嘌呤/嘧啶核糖核酸内切酶-1(Ape-1),细胞间黏附分子(ICAM)-1和白介素(IL)-17A对于治疗,将分别具有4.2、3.0和5.1 µg / l的临界值的SBRT分为A组和B组。患者在计划目标量范围内接受了放射剂量。立体定向放射疗法(SBRT)用于治疗NSCLC,单光子发射计算机断层扫描肺灌注成像用于评估所有患者是否存在RP。此外,通过ELISA检查血清Ape-1,ICAM-1和IL-17A的水平。在进行SBRT之前,灌注图像表明任何患者均无RP,并且23例患者的Ape-1,ICAM-1和IL-17A水平较高。 SBRT后,A组23例患者中有22例(95.65%)表现为RP,1例患者(4.35%)没有RP。在B组中,SBRT后23例患者中有6例(26.09%)有RP,17例(73.91%)没有RP。两组RP的发生率差异有统计学意义(P = 1.66×10 -12 <0.05)。总之,高水平的Ape-1,ICAM-1和IL-17A与RP风险增加有关。将来应进行进一步分析,以验证这些因素是否具有重大的预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号